These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6089187)
1. Dose-related effect of acetylsalicylic acid on replication of varicella zoster virus in vitro. Walz-Cicconi MA; Weller TH Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5223-6. PubMed ID: 6089187 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus. Primache V; Binda S; De Benedittis G; Barbi M New Microbiol; 1998 Oct; 21(4):397-401. PubMed ID: 9812322 [TBL] [Abstract][Full Text] [Related]
3. Effects of tumor necrosis factor alpha on replication of varicella-zoster virus. Ito M; Nakano T; Kamiya T; Kitamura K; Ihara T; Kamiya H; Sakurai M Antiviral Res; 1991; 15(3):183-92. PubMed ID: 1653555 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues. Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364 [TBL] [Abstract][Full Text] [Related]
5. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus. Shiraki K; Ochiai H; Namazue J; Okuno T; Ogino S; Hayashi K; Yamanishi K; Takahashi M Antiviral Res; 1992 Jun; 18(2):209-14. PubMed ID: 1329651 [TBL] [Abstract][Full Text] [Related]
7. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Shigeta S; Yokota T; De Clercq E Antiviral Res; 1985; Suppl 1():35-44. PubMed ID: 3002264 [No Abstract] [Full Text] [Related]
8. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure. Machida H; Nishitani M; Ashida N Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297 [TBL] [Abstract][Full Text] [Related]
9. The effect of phosphonoacetic acid on the in vitro replication of varicella-zoster virus. May DC; Miller MR; Rapp F Intervirology; 1977; 8(2):83-91. PubMed ID: 192695 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro. Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502 [TBL] [Abstract][Full Text] [Related]
12. Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro. Iltis JP; Lin TS; Prusoff WH; Rapp F Antimicrob Agents Chemother; 1979 Jul; 16(1):92-7. PubMed ID: 224809 [TBL] [Abstract][Full Text] [Related]
13. Human Embryonic Stem Cell-Derived Neurons Are Highly Permissive for Varicella-Zoster Virus Lytic Infection. Sadaoka T; Schwartz CL; Rajbhandari L; Venkatesan A; Cohen JI J Virol; 2018 Jan; 92(1):. PubMed ID: 29046461 [TBL] [Abstract][Full Text] [Related]
14. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus. Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971 [TBL] [Abstract][Full Text] [Related]